CRONRecord numbers, not just record-breaking vibes
Cronos said Q1 2026 net revenue jumped 40% year over year to $45.2 million, and gross profit hit a new high too. That’s the kind of quarter that makes management sound like it’s got a little extra swagger — and in fairness, it kind of does.
Where the growth is coming from
The company pointed to a few bright spots:
- It grabbed the No. 1 market share spot in vapes in Canada.
- Israel turned in its ninth straight quarter of record net revenue, with PEACE NATURALS staying the country’s top cannabis brand.
- Cronos also said extra supply from the Cronos GrowCo expansion is helping fuel the next phase of growth.
Why investors should care
This isn’t just about one good quarter. Cronos is trying to prove it can turn brand strength and supply expansion into durable sales momentum, not just a temporary sugar rush. And with $822 million in cash and cash equivalents, it’s got a balance sheet that most cannabis names would probably love to borrow for a weekend.
Big picture: if Cronos can keep stacking quarters like this, the market may start treating it less like a cannabis lottery ticket and more like a real operating story.